Simulations Plus (SLP) Partners with Large Pharmaceutical Company to Advance ADMET Predictor Machine Learning Software
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Simulations Plus (SLP) Misses Q2 EPS by 2c, Revenues Beat
April 9, 2020 4:47 PM EDTSimulations Plus (NASDAQ: SLP) reported Q2 EPS of $0.12, $0.02 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $9.86 million.
2QFY20 highlights compared with 2QFY19:
Net revenues increased 22.2%, or $1.9 million, to $10.3 million from $8.5 millionGross profit was $7.7 million, up $1.4 million, or 22.7%, from $6.3 millionSG&A was $4.1 million, up $1.3 million, or 46.3%, from $2.8 millionSG&A as a percentage of revenues increased to 39.7% from 33.2%, inclusive of $350,000 in transaction costs related to the Lixoft acquisitionR&D expense increased 3.3%, or $23,600, to $748,000 from $724,000Income before taxes increased 5.2%, or $140,500, to... More